Bifonazole
Especificaciones
60628-96-8Número CAS
262-336-6Número CE
1-[phenyl-(4-phenylphenyl)methyl]imidazoleNombre IUPAC
C22H18N2Fórmula química
310.4 g/molPeso molecular
bifonazole; 60628-96-8; Mycospor; Trifonazole; Bifonazol; BAY H 4502; Bifonazolum; 1-((4-Biphenylyl)phenylmethyl)-1H-imidazole; 1-(alpha-(4-Biphenylyl)benzyl)imidazole; Bay-h-4502; Bay H-4502; (+-)-1-(p,alpha-Diphenylbenzyl)imidazole; DTXSID9045631; NSC-758954; QYJ305Z91O; D01AC10; DTXCID7025631; 1-((4-biphenylyl)-phenylmethyl)-1H-imidazole; 1H-Imidazole, 1-((1,1'-biphenyl)-4-ylphenylmethyl)-, (+-)-; 1-(phenyl(4-phenylphenyl)methyl)-1H-imidazole; 1-[phenyl(4-phenylphenyl)methyl]-1H-imidazole; bifonazolo; RefChem:568329; CHEBI:31286; 1-((RS)-(Biphenyl-4-yl)(phenyl)methyl)-1H-imidazole; 262-336-6; Amycor; Azolmen; 1-[phenyl-(4-phenylphenyl)methyl]imidazole; Bifonazol [INN-Spanish]; Bifonazolum [INN-Latin]; 1H-Imidazole, 1-([1,1'-biphenyl]-4-ylphenylmethyl)-; 1-([1,1'-Biphenyl]-4-yl(phenyl)methyl)-1H-imidazole; (+/-)-Bifonazole; 1-(p,alpha-Diphenylbenzyl)imidazole; MFCD00865567; MLS000028576; CHEMBL277535; 1-[biphenyl-4-yl(phenyl)methyl]-1H-imidazole; 1H-Imidazole, 1-((1,1'-biphenyl)-4-ylphenylmethyl)-; (+-)1-([1,1'-Biphenyl]-4-ylphenylmethyl)-1H-imidazole; NCGC00018254-03; SMR000058970; 1-[biphenyl-4-yl(phenyl)methyl]imidazole; 1-(ALPHA,4-DIPHENYLBENZYL)IMIDAZOLE; 1-({[1,1'-biphenyl]-4-yl}(phenyl)methyl)-1H-imidazole; Mycospor (TN); CAS-60628-96-8; SR-01000003136; EINECS 262-336-6; BRN 0618427; 1-[([1,1'-Biphenyl]-4-yl)(phenyl)methyl]-1H-imidazole; UNII-QYJ305Z91O; Mycosporan; Bedriol; Mycosporan;; Bifazole;; Mycospor;; Bifonazole CRS; Bifonazole [USAN:INN:BAN:JAN]; Bifonazole (Standard); CPD000058970; BIFONAZOLE [MI]; BIFONAZOLE [INN]; BIFONAZOLE [JAN]; 1-[PHENYL-(4-PHENYLPHENYL)-METHYL]IMIDAZOLE; Opera_ID_1656; Spectrum2_000035; Spectrum3_001970; (.+/-.)-Bifonazole; BIFONAZOLE [USAN]; Imidazole, 1-(alpha-(4-biphenylyl)benzyl)-; 1-(Biphenyl-4-yl-phenyl-methyl)-1H-imidazole; BIFONAZOLE [MART.]; cid_2378; BIFONAZOLE [WHO-DD]; SCHEMBL36803; BSPBio_003570; 5-23-04-00292 (Beilstein Handbook Reference); MLS000759537; MLS001074074; MLS001424050; SPECTRUM1505309; SPBio_000129; Bifonazole - Bio-X trade mark; orb1224488; orb1309472; orb3139347; Bifonazole (JP18/USAN/INN); BIFONAZOLE [EP IMPURITY]; Bifonazole, >=98% (HPLC); CHEBI:78692; HY-B0301R; KBio3_002922; 1-(p,?-Diphenylbenzyl)imidazole; BIFONAZOLE [EP MONOGRAPH]; GLXC-01551; HMS1922B18; HMS2051F04; HMS2090K13; HMS2093B09; HMS2232J24; HMS3374H02; HMS3393F04; HMS3651G21; HMS3715L21; HMS5080M15; Pharmakon1600-01505309; HY-B0301; MSK10152; Tox21_110850; BDBM50128548; CCG-39996; DL-338; EBC-01060; NSC758954; s1854; STK618771; Bifonazole for system suitability CRS; AKOS005553008; Tox21_110850_1; AB07497; CCG-100993; DB04794; FP36903; KS-5111; NC00243; NSC 758954; [phenyl(4-phenylphenyl)methyl]imidazole; MRF-0000274; NCGC00018254-02; NCGC00018254-04; NCGC00018254-05; NCGC00018254-08; NCGC00018254-09; NCGC00089815-02; NCGC00089815-03; NCGC00089815-04; AC-15414; BP164253; DA-51112; SY052768; SBI-0206755.P001; 1-(.alpha.-(4-Biphenylyl)benzyl)imidazole; 1-[alpha-(4-biphenylyl)-benzyl]-imidazole; (Biphenyl-4-yl)-imidazol-1-yl-phenylmethane; B4173; NS00003619; ST50993921; SW197623-3; 1-[4-Biphenylyl(phenyl)methyl]-1H-imidazole; VU0239694-7; D01775; EN300-295624; Imidazole, 1-(.alpha.-(4-biphenylyl)benzyl)-; AB00383029-16; AB00383029_17; AB00383029_18; (.+/-.)-1-(p,.alpha.-Diphenylbenzyl)imidazole; F806741; Q421162; 1-(1-Biphenyl-4-yl-2-phenyl-methyl)-1H-imidazole; SR-01000003136-4; SR-01000003136-6; (+/-)-1-(P,.ALPHA.-DIPHENYLBENZYL)IMIDAZOLE; BRD-A94543220-001-02-3; BRD-A94543220-001-12-2; BRD-A94543220-001-23-9; BRD-A94543220-001-24-7; Z275375166; 1-(Biphenyl-4-yl-phenyl-methyl)-1H-imidazole (bifonazole); 1-(Biphenyl-4-yl-phenyl-methyl)-1H-imidazole( Bifanozole); 1-(Biphenyl-4-yl-phenyl-methyl)-1H-imidazole(Bifonazole); 1-[[1,1'-Biphenyl]-4-yl(phenyl)methyl]-1H-imidazole #; Bifonazole, European Pharmacopoeia (EP) Reference Standard; 1H-Imidazole, 1-([1,1'-biphenyl]-4-ylphenylmethyl)-, (.+/-.)-; 1H-IMIDAZOLE, 1-((1,1'-BIPHENYL)-4-YLPHENYLMETHYL)-, (+/-)-; Bifonazole, Pharmaceutical Secondary Standard; Certified Reference Material; Bifonazole for system suitability, European Pharmacopoeia (EP) Reference StandardSinónimos
Productos que contienen Bifonazole
카네스텐원스데일리크림(비포나졸)스퍼나졸연고(비포나졸)(수출명:BIFONA-ZOINTMENT)LEVELINA 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEALEVELINA 10 mg/g POLVO CUTANEOLEVELINA 10 mg/g CREMACANESPIE BIFONAZOL 10 mg/ml SOLUCION PARA PULVERIZACION CUTANEACANESPIE BIFONAZOL 10 mg/g CREMABIFONAZOLE SUBSTIPHARM 1 %, crèmeAMYCOR ONYCHOSET, pommadeAMYCOR 1 POUR CENT, poudre pour application locale en flacon poudreurAMYCOR 1 POUR CENT, crème pour application localeBifonazole
Página 1 de 2
